440 related articles for article (PubMed ID: 33050856)
1. Research Progresses of Targeted Therapy and Immunotherapy for Hepatocellular Carcinoma.
Wang T; Zhang Q; Wang N; Liu Z; Zhang B; Zhao Y
Curr Med Chem; 2021; 28(16):3107-3146. PubMed ID: 33050856
[TBL] [Abstract][Full Text] [Related]
2. Molecular targeted and immune checkpoint therapy for advanced hepatocellular carcinoma.
Liu Z; Lin Y; Zhang J; Zhang Y; Li Y; Liu Z; Li Q; Luo M; Liang R; Ye J
J Exp Clin Cancer Res; 2019 Nov; 38(1):447. PubMed ID: 31684985
[TBL] [Abstract][Full Text] [Related]
3. New Therapeutic Options for Advanced Hepatocellular Carcinoma.
Ma YS; Liu JB; Wu TM; Fu D
Cancer Control; 2020; 27(3):1073274820945975. PubMed ID: 32799550
[TBL] [Abstract][Full Text] [Related]
4. [Clinical research progression of molecular-targeted drugs and PD-1 inhibitors for advanced hepatocellular carcinoma].
Lai JM; Hu S; Lin H; Luo H; Luo YB
Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):406-409. PubMed ID: 31216824
[TBL] [Abstract][Full Text] [Related]
5. Molecular therapies and precision medicine for hepatocellular carcinoma.
Llovet JM; Montal R; Sia D; Finn RS
Nat Rev Clin Oncol; 2018 Oct; 15(10):599-616. PubMed ID: 30061739
[TBL] [Abstract][Full Text] [Related]
6. Advances in novel systemic therapies for advanced hepatocellular carcinoma.
Carloni R; Rizzo A; Cusmai A; Palloni A; Federico AD; Marco MD; Massafra R; Fanizzi A; Palmiotti G; Brandi G
Future Med Chem; 2022 Oct; 14(20):1455-1470. PubMed ID: 35997677
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of the systemic treatment in advanced hepatocellular carcinoma.
De Mattia E; Cecchin E; Guardascione M; Foltran L; Di Raimo T; Angelini F; D'Andrea M; Toffoli G
World J Gastroenterol; 2019 Aug; 25(29):3870-3896. PubMed ID: 31413525
[TBL] [Abstract][Full Text] [Related]
8. Recent Progress in Systemic Therapy for Advanced Hepatocellular Carcinoma.
Sadagopan N; He AR
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279258
[TBL] [Abstract][Full Text] [Related]
9. Emerging drugs for the treatment of hepatocellular carcinoma.
Ayoub WS; Jones PD; Yang JD; Martin P
Expert Opin Emerg Drugs; 2022 Jun; 27(2):141-149. PubMed ID: 35642526
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and immune checkpoint dual blockade: Opportunities and challenges for hepatocellular carcinoma therapy.
Li SQ; Yang Y; Ye LS
World J Gastroenterol; 2022 Nov; 28(42):6034-6044. PubMed ID: 36405383
[TBL] [Abstract][Full Text] [Related]
11. [Status Quo and Development of Immunotherapy for Hepatocellular Carcinoma].
Wang T; Wang WT
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):692-698. PubMed ID: 37248607
[TBL] [Abstract][Full Text] [Related]
12. Immunomodulatory Effects of Current Targeted Therapies on Hepatocellular Carcinoma: Implication for the Future of Immunotherapy.
Lin YY; Tan CT; Chen CW; Ou DL; Cheng AL; Hsu C
Semin Liver Dis; 2018 Nov; 38(4):379-388. PubMed ID: 30357775
[TBL] [Abstract][Full Text] [Related]
13. [Clinical advances in targeted therapy and immunotherapy for hepatocellular carcinoma].
Zhang DZ; Niu JQ
Zhonghua Gan Zang Bing Za Zhi; 2019 Nov; 27(11):834-837. PubMed ID: 31941237
[TBL] [Abstract][Full Text] [Related]
14. Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma.
Villarruel-Melquiades F; Mendoza-Garrido ME; García-Cuellar CM; Sánchez-Pérez Y; Pérez-Carreón JI; Camacho J
World J Gastroenterol; 2023 May; 29(17):2571-2599. PubMed ID: 37213397
[TBL] [Abstract][Full Text] [Related]
15. New insights into the pharmacological, immunological, and CAR-T-cell approaches in the treatment of hepatocellular carcinoma.
Dal Bo M; De Mattia E; Baboci L; Mezzalira S; Cecchin E; Assaraf YG; Toffoli G
Drug Resist Updat; 2020 Jul; 51():100702. PubMed ID: 32371296
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of hepatocellular carcinoma: strategies for combinatorial intervention.
Tian M; Shi Y; Liu W; Fan J
Sci China Life Sci; 2019 Sep; 62(9):1138-1143. PubMed ID: 31119560
[TBL] [Abstract][Full Text] [Related]
17. Progress in systemic therapy of advanced hepatocellular carcinoma.
Gong XL; Qin SK
World J Gastroenterol; 2016 Aug; 22(29):6582-94. PubMed ID: 27547002
[TBL] [Abstract][Full Text] [Related]
18. Systemic therapy for hepatocellular carcinoma: beyond sorafenib.
Boland P; Wu J
Chin Clin Oncol; 2018 Oct; 7(5):50. PubMed ID: 30395717
[TBL] [Abstract][Full Text] [Related]
19. Oral chemotherapy for the treatment of hepatocellular carcinoma.
Yamamoto S; Kondo S
Expert Opin Pharmacother; 2018 Jun; 19(9):993-1001. PubMed ID: 29913090
[TBL] [Abstract][Full Text] [Related]
20. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma.
Bresnahan E; Lindblad KE; Ruiz de Galarreta M; Lujambio A
Clin Cancer Res; 2020 Oct; 26(20):5276-5286. PubMed ID: 32327473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]